Tirzepatide is a once-weekly injectable that hits both GIP and GLP-1 receptors. It's designed to help with blood sugar control and weight loss.
How it works
Tirzepatide activates two hormone receptors instead of one, which gives you broader metabolic coverage. It boosts insulin release when your glucose is up, turns down appetite and food intake, and slows how fast your stomach empties.
Why dual action stands out
Hitting two pathways at once helps with blood sugar from multiple angles. You dose it once a week, which keeps things simple. When you pair it with real lifestyle changes, you get meaningful weight reduction and better long-term metabolic health.
Dosing and safety
Dosing typically starts low and increases gradually over several weeks as tolerated, taken once weekly on the same day each week, with injection sites rotated between the abdomen, thigh, or upper arm. The most common side effects are nausea, diarrhea, vomiting, constipation, and decreased appetite. It is not used in patients with a personal or family history of medullary thyroid carcinoma or MEN 2, and pancreatitis, gallbladder disease, and kidney risks from dehydration are discussed before starting - used only under clinician guidance.
This is a cash-pay metabolic program for adults, available to New Mexico residents, and is separate from psychiatric care. Tirzepatide is a tool that works best with nutrition, movement, and consistency, not a substitute for either.
Kevin Lazar, MSN, APRN, PMHNP-BC · WellnessRx · View the study
If you are in crisis, call or text 988 (Suicide & Crisis Lifeline). Medications prescribed only when clinically appropriate. Individual results vary. Telehealth services available to New Mexico residents. Compounded medications are not FDA-approved as products.